Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 1, 2020.
Big biotech company Amgen is joining the race to discover new drugs that can treat the novel coronavirus, the latest drugmaker redirecting resources toward the pandemic.
After plunging dramatically at the beginning of the month, biopharmaceutical equities appear to be recovering some of the valuation they originally lost when the financial markets cratered. ...
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 2, 2020.
These are difficult times. But two of the top biotech venture firms just raised a total of $2.6 billion to fund new startups.
GlaxoSmithKline has announced plans to collaborate China’s Xiamen Innovex on a potential vaccine to treat the COVID-19 coronavirus.
The coronavirus pandemic has fundamentally disrupted the biotech industry. But the second quarter still promises to be an extremely busy one.
As the novel coronavirus continues to spread, scientists and researchers are working around the clock to identify diagnostics, therapeutics and vaccines to help protect individuals and ...